Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. (Q48484439)
Jump to navigation
Jump to search
scientific article published in April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. |
scientific article published in April 1998 |
Statements
Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group (English)
S O Heard
M P Fink
R L Gamelli
M Joshi
A L Trask
T C Fabian
L D Hudson
K B Gerold
1 April 1998